Endothelial NO/cGMP/VASP Signaling Attenuates Kupffer Cell Activation and Hepatic Insulin Resistance Induced by High-Fat Feeding
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Proinflammatory activation of Kupffer cells is implicated in the effect of high-fat feeding to cause liver insulin resistance. We sought to determine whether reduced endothelial nitric oxide (NO) signaling contributes to the effect of high-fat feeding to increase hepatic inflammatory signaling and if so, whether this effect 1) involves activation of Kupffer cells and 2) is ameliorated by increased NO signaling. RESEARCH DESIGN AND METHODS: Effect of NO/cGMP signaling on hepatic inflammation and on isolated Kupffer cells was examined in C57BL/6 mice, eNos−/− mice, and Vasp−/− mice fed a low-fat or high-fat diet. RESULTS: We show that high-fat feeding induces proinflammatory activation of Kupffer cells in wild-type mice coincident with reduced liver endothelial nitric oxide synthase activity and NO content while, conversely, enhancement of signaling downstream of endogenous NO by phosphodiesterase-5 inhibition protects against high fat–induced inflammation in Kupffer cells. Furthermore, proinflammatory activation of Kupffer cells is evident in eNos−/− mice even on a low-fat diet. Targeted deletion of vasodilator-stimulated phosphoprotein (VASP), a key downstream target of endothelially derived NO, similarly predisposes to hepatic and Kupffer cell inflammation and abrogates the protective effect of NO signaling in both macrophages and hepatocytes studied in a cell culture model. CONCLUSIONS: These results collectively imply a physiological role for endothelial NO to limit obesity-associated inflammation and insulin resistance in hepatocytes and support a model in which Kupffer cell activation during high-fat feeding is dependent on reduced NO signaling. Our findings also identify the NO/VASP pathway as a novel potential target for the treatment of obesity-associated liver insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In health, LSECs regulate anti-inflammatory and antifibrotic signalling by preventing KC and HSC activation via nitric oxide, cGMP and VASP (vasodilator stimulated phosphoprotein).138”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [138]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophages, inflammation, and insulin resistance
Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733 · cited 2×
“Growing evidence suggests that inflammatory signaling pathways mediate insulin resistance induced by nutrient excess in both cultured hepatocytes and in hepatic tissue in vivo (2,4,7,20).”
BackgroundKanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682 · cited 1×
“Hepatic triglyceride content was measured in liver lysates as previously described (18).”
MethodIKK-β links inflammation to obesity-induced insulin resistance
Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M. (2005) · Nature Medicine · doi:10.1038/nm1185 · Cited by 1,773
Insulin and insulin resistance:
Sowers, J. R., & Frohlich, E. D. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00128-7 · Cited by 1,518
Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance
Odegaard, J. I., Ricardo-Gonzalez, R. R., Red Eagle, A., Vats, D., Morel, C. R., Goforth, M. H., Subramanian, V., Mukundan, L., Ferrante, A. W., & Chawla, A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.04.003 · Cited by 847 · cited 2×
“Because Kupffer cells play an important role in the development of hepatic insulin resistance during high-fat feeding (2,20), we next sought to investigate the time course of Kupffer cell activation during high-fat feeding in normal mice using a validated Kupffer cell isolation method (3).”
MethodStructural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review
Braet, F., & Wisse, E. (2002) · Comparative Hepatology · doi:10.1186/1476-5926-1-1 · Cited by 753 · cited 1×
“The liver is a highly vascularized tissue receiving 20% of cardiac output, and hepatic sinusoidal endothelial cells make up 50% of nonparenchymal cells of the liver (8,9).”
BackgroundFundamentals of Endothelial Function for the Clinical Cardiologist
Verma, S., & Anderson, T. J. (2002) · Circulation · doi:10.1161/hc0502.104540 · Cited by 602
Toll-Like Receptor-4 Mediates Vascular Inflammation and Insulin Resistance in Diet-Induced Obesity
Kim, F., Pham, M., Luttrell, I., Bannerman, D. D., Tupper, J., Thaler, J., Hawn, T. R., Raines, E. W., & Schwartz, M. W. (2007) · Circulation Research · doi:10.1161/circresaha.106.142851 · Cited by 584 · cited 3×
“During the final 2 weeks of the highfat feeding protocol, mice on each diet received daily oral administration of either vehicle or the phosphodiesterase-5 (PDE-5) inhibitor sildenafil at a dose (30 mg/kg per day) that did not affect weight gain on either diet compared with the vehicle control group (15).”
MethodInfluentialSelf-citationDuplain, H., Burcelin, R., Sartori, C., Cook, S., Egli, M., Lepori, M., Vollenweider, P., Pedrazzini, T., Nicod, P., Thorens, B., et al. (2001) · Circulation · doi:10.1161/01.cir.104.3.342 · Cited by 533 · cited 1×
“Previous investigators have demonstrated that deletion of eNOS results in increased systemic insulin resistance (21,27).”
BackgroundHuang, W., Metlakunta, A., Dedousis, N., Zhang, P., Sipula, I., Dube, J. J., Scott, D. K., & O'Doherty, R. M. (2010) · Diabetes · doi:10.2337/db09-0016 · Cited by 520 · cited 1×
“Depletion of Kupffer cells using gadolinium chloride attenuated the development of hepatic steatosis and hepatic insulin resistance, suggesting an important early role for Kupffer cells in diet-induced alterations in hepatic insulin resistance (1).”
Background
Cited by
Dixon, L. J., Barnes, M., Tang, H., Pritchard, M. T., & Nagy, L. E. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120026 · Cited by 628
“For example, recent studies have found that high-fat diets increase Kupffer cell activation in a time-dependent mechanism, leading to increased expression of inflammatory cytokines and iNOS expression, due, at least in part, to reduced endothelial NO signalling in the liver (136).”
Redox control of inflammation in macrophages
Brüne, B., Dehne, N., Grossmann, N., Jung, M., Namgaladze, D., Schmid, T., von Knethen, A., & Weigert, A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4785 · Cited by 377
“A cGMP increase in macrophages protects against NO-, ONOO - -, or oxLDL-induced toxicity (112), attenuates proinflammatory cytokine production in LPS-stimulated macrophages (147), reduces high-fat-evoked proinflammatory cytokine production as well as the recruitment of macrophages into adipose tissue (103), and limits…”
BackgroundRole of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease
Hammoutene, A., & Rautou, P.-E. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.012 · Cited by 364
Nitric oxide in liver diseases
Iwakiri, Y., & Kim, M. Y. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.05.001 · Cited by 300
“NO keeps hepatic stellate cells (HSCs) [63, 64] and Kupffer cells quiescent [73].”
BackgroundMacrophage functional diversity in NAFLD — more than inflammation
Barreby, E., Chen, P., & Aouadi, M. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00675-6 · Cited by 247
Recent advances in obesity-induced inflammation and insulin resistance
Tateya, S., Kim, F., & Tamori, Y. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00093 · Cited by 211
“Although HFD feeding caused M1 activation of Kupffer cells in the liver (50, 51), it seemed that the number of Kupffer cells was not increased in obesity (53).”
BackgroundResultSelf-citationThe evolving role of liver sinusoidal endothelial cells in liver health and disease
McConnell, M. J., Kostallari, E., Ibrahim, S. H., & Iwakiri, Y. (2023) · Hepatology · doi:10.1097/hep.0000000000000207 · Cited by 189
“Decreased production of eNOS-derived NO is a fundamental characteristic of LSEC dysfunction across disease etiologies (85), and LSEC-produced NO protects the liver from fibrosis by preventing activation of hepatic stellate cells(86, 87).”
Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison?
Gruben, N., Shiri‐Sverdlov, R., Koonen, D. P. Y., & Hofker, M. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.08.004 · Cited by 167
“In another study, it was shown that Kupffer cells became activated within 4 weeks of a high fat diet, through reduced nitric oxide signaling [105].”
BackgroundThe Endothelium as a Driver of Liver Fibrosis and Regeneration
Lafoz, E., Ruart, M., Anton, A., Oncins, A., & Hernández-Gea, V. (2020) · Cells · doi:10.3390/cells9040929 · Cited by 149
Increased cGMP promotes healthy expansion and browning of white adipose tissue
Mitschke, M. M., Hoffmann, L. S., Gnad, T., Scholz, D., Kruithoff, K., Mayer, P., Haas, B., Sassmann, A., Pfeifer, A., & Kilić, A. (2013) · The FASEB Journal · doi:10.1096/fj.12-221580 · Cited by 143
“(38) implicated cGMP signaling in reduction of NF- B signaling in both hepatocytes and macrophages.”
BackgroundInfluentialThe Role of Sinusoidal Endothelial Cells in the Axis of Inflammation and Cancer Within the Liver
Wilkinson, A. L., Qurashi, M., & Shetty, S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00990 · Cited by 121
Thorn, S. R., Baquero, K. C., Newsom, S. A., El Kasmi, K. C., Bergman, B. C., Shulman, G. I., Grove, K. L., & Friedman, J. E. (2014) · Diabetes · doi:10.2337/db14-0276 · Cited by 119
Understanding the cellular interactome of non-alcoholic fatty liver disease
Wallace, S. J., Tacke, F., Schwabe, R. F., & Henderson, N. C. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100524 · Cited by 116
“In health, LSECs regulate anti-inflammatory and antifibrotic signalling by preventing KC and HSC activation via nitric oxide, cGMP and VASP (vasodilator stimulated phosphoprotein).(138) Like KCs, LSECs express TLR4 receptors that”
BackgroundCrosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis
Li, H., Zhou, Y., Wang, H., Zhang, M., Qiu, P., Zhang, M., Zhang, R., Zhao, Q., & Liu, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01169 · Cited by 114
“Kupffer Cells–Liver Sinusoidal Endothelial Cells At the early stage of NAFLD, LSECs exhibited an antiinflammatory property by inhibiting KC activation and monocyte migration (81, 82).”
BackgroundEstablished and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease
Tzoumas, N., Farrah, T. E., Dhaun, N., & Webb, D. J. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14920 · Cited by 123
Maslak, E., Gregorius, A., & Chlopicki, S. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.04.010 · Cited by 112
“Fasmediated apoptosis was limited by KC released interleukin-6 binding to glycoprotein 130 on LSECs surface [56], while LSECderived NO limited the activation of KC [57].”
BackgroundM2 Macrophage Polarization Mediates Anti-inflammatory Effects of Endothelial Nitric Oxide Signaling
Lee, W. J., Tateya, S., Cheng, A. M., Rizzo, N. O., Wang, N. F., Handa, P., Wilson, C. L., Clowes, A. W., Sweet, I. R., Bomsztyk, K., et al. (2015) · Diabetes · doi:10.2337/db14-1668 · Cited by 114
“Our previous studies demonstrated that HFD feeding reduces hepatic VASP serine 239 phosphorylation as well as NO content (19), and deficiency of either VASP or eNOS mimic the effect of HFD feeding to induce hepatic NF-kB activation and insulin resistance (19).”
BackgroundResultInfluentialSelf-citationThibaut, R., Gage, M. C., Pineda‐Torra, I., Chabrier, G., Venteclef, N., & Alzaid, F. (2022) · The FEBS Journal · doi:10.1111/febs.15877 · Cited by 95
Endothelial Dysfunction in Diabetes
Takeda, Y., Matoba, K., Sekiguchi, K., Nagai, Y., Yokota, T., Utsunomiya, K., & Nishimura, R. (2020) · Biomedicines · doi:10.3390/biomedicines8070182 · Cited by 105
“Previous studies focusing on insulin resistance have revealed the endothelial NO/VASP-mediated suppression of inflammation in adipose tissue and liver [60,61].”
BackgroundLiver innate immune cells and insulin resistance: the multiple facets of Kupffer cells
Jager, J., Aparicio‐Vergara, M., & Aouadi, M. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12483 · Cited by 90
Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions
Xu, G.-X., Wei, S., Yu, C., Zhao, S.-Q., Yang, W.-J., Feng, Y.-H., Pan, C., Yang, K.-X., & Ma, Y. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1199519 · Cited by 88
Gopallawa, I., Freund, J. R., & Lee, R. J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03494-y · Cited by 93
Angiocrine signaling in sinusoidal homeostasis and liver diseases
Gao, J., Lan, T., Kostallari, E., Guo, Y., Lai, E., Guillot, A., Ding, B., Tacke, F., Tang, C., & Shah, V. H. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.05.014 · Cited by 90
Mechanotransduction in the pathogenesis of non-alcoholic fatty liver disease
Mitten, E. K., & Baffy, G. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.08.028 · Cited by 79
Yang, Y., Sangwung, P., Kondo, R., Jung, Y., McConnell, M. J., Jeong, J., Utsumi, T., Sessa, W. C., & Iwakiri, Y. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.02.028 · Cited by 78
Matsumoto, M., Zhang, J., Zhang, X., Liu, J., Jiang, J. X., Yamaguchi, K., Taruno, A., Katsuyama, M., Iwata, K., Ibi, M., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.12.019 · Cited by 77
Discovery of a Phosphodiesterase 9A Inhibitor as a Potential Hypoglycemic Agent
Shao, Y., Huang, M., Cui, W., Feng, L.-J., Wu, Y., Cai, Y.-H., Li, Z., Zhu, X., Liu, P., Wan, Y., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500836h · Cited by 78
de Matos, A. M., de Macedo, M. P., & Rauter, A. P. (2018) · Medicinal Research Reviews · doi:10.1002/med.21440 · Cited by 66
Flores‐Costa, R., Duran‐Güell, M., Casulleras, M., López‐Vicario, C., Alcaraz‐Quiles, J., Díaz, A., Lozano, J. J., Titos, E., Hall, K., Sarno, R., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000466117 · Cited by 66
“Of interest, in our study, inhibition of NF-κB by PRL was associated with increased VASP Ser239 phosphorylation, which is a well-stablished downstream target of cGMP-dependent kinases and plays a crucial role in the antiinflammatory signaling of sGC (26, 27).”
Bravo, M., Raurell, I., Hide, D., Fernández‐Iglesias, A., Gil, M., Barberá, A., Salcedo, M. T., Augustín, S., Genescà, J., & Martell, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-56366-2 · Cited by 70
IRAK3 modulates downstream innate immune signalling through its guanylate cyclase activity
Freihat, L., Wheeler, J. I., Wong, A., Turek, I., Manallack, D. T., & Irving, H. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-51913-3 · Cited by 64
eNOS deletion impairs mitochondrial quality control and exacerbates Western diet-induced NASH
Sheldon, R. D., Meers, G. M.-E., Morris, E. M., Linden, M. A., Cunningham, R. P., Ibdah, J. A., Thyfault, J. P., Laughlin, M. H., & Rector, R. S. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00096.2019 · Cited by 59
Qin, L., Zang, M., Xu, Y. C., Zhao, R., Wang, Y., Mi, Y., & Mei, Y. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000810 · Cited by 56
Du, W., & Wang, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.936196 · Cited by 56
“org 6 main mechanisms leading to this result include high lipid exposure, insulin resistance and intestinal flora imbalance (81).”
BackgroundGüney, C., Bal, N. B., & Akar, F. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e18896 · Cited by 60
“Further studies explored that there was a functional link between insulin signaling and eNOS [146,147].”
BackgroundAlam, M. A., Kauter, K., Withers, K., Sernia, C., & Brown, L. (2012) · Food & Function · doi:10.1039/c2fo30096f · Cited by 52
Emerging Roles of Liver Sinusoidal Endothelial Cells in Nonalcoholic Steatohepatitis
Furuta, K., Guo, Q., Hirsova, P., & Ibrahim, S. H. (2020) · Biology · doi:10.3390/biology9110395 · Cited by 48
“In addition, mice lacking eNOS, which generates endothelial NO, had increased macrophage-associated hepatic inflammation even when fed a low fat diet [39].”
BackgroundThe relationships between high-fat diet and metabolic syndrome: Potential mechanisms
Tang, C., Wang, Y., Xu, Z., Chen, D., Xu, J., Yang, D., Zhang, L., Liu, J., & Kan, J. (2024) · Food Bioscience · doi:10.1016/j.fbio.2024.104261 · Cited by 51
Regulation of metabolism by cGMP
Pfeifer, A., Kilić, A., & Hoffmann, L. S. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.06.001 · Cited by 56
Chalasani, N., Vuppalanchi, R., Rinella, M., Middleton, M. S., Siddiqui, M. S., Barritt, A. S., Kolterman, O., Flores, O., Alonso, C., Iruarrizaga‐Lejarreta, M., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14674 · Cited by 40
Wang, X.-K., & Peng, Z.-G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.655557 · Cited by 40
Akar, F., Şumlu, E., Alçığır, M. E., Bostancı, A., & Sadı, G. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110287 · Cited by 45
Organoid-guided precision hepatology for metabolic liver disease
Osonoi, S., & Takebe, T. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.01.002 · Cited by 45
Role of NO/VASP Signaling Pathway against Obesity-Related Inflammation and Insulin Resistance
Kang, Y. M., Kim, F., & Lee, W. J. (2017) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2017.41.2.89 · Cited by 41
“Furthermore, genetic deletion of endothelial nitric oxide synthase (eNOS) is associated with insulin resistance even in the absence of high-fat (HF) stimuli [11].”
BackgroundSelf-citationChronic NOS inhibition accelerates NAFLD progression in an obese rat model
Sheldon, R. D., Padilla, J., Jenkins, N. T., Laughlin, M. H., & Rector, R. S. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00247.2014 · Cited by 38
Shan, S., Qiao, Q., Yin, R., Zhang, L., Shi, J., Zhao, W., Zhou, J., & Li, Z. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c05764 · Cited by 38
Zemel, M., Fu, L., Li, F., Bruckbauer, A., Cao, Q., Wu, R., Shi, H., Xue, B., & Cui, X. (2015) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s82338 · Cited by 36
“diet-induced obesity and insulin resistance suppress hepatic eNOS activity prior to the induction of hepatic inflammation, while increasing NO signaling with sildenafil restored hepatic insulin signaling and prevented dietary fat-induced nuclear factor-kappaB (NFκB)-mediated hepatic inflammation.(43) The combination o…”
Zeng, T., Liu, F.-M., Zhou, J., Pan, S.-X., Xia, W., & Chen, L. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0046 · Cited by 38
Minciună, I., Taru, M. G., Procopeț, B., & Ştefănescu, H. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051406 · Cited by 42
“Activation of KCs promotes inflammation by triggering the induction of nuclear factor-κ B and upregulation of pro-inflammatory factors TNF-α and IL-6, as shown in murine experiments [51].”
BackgroundGut‐liver‐axis: Barrier function of liver sinusoidal endothelial cell
Wang, Y., & Liu, Y. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15512 · Cited by 36
Endotheliopathy in the metabolic syndrome: Mechanisms and clinical implications
Furuta, K., Tang, X., Islam, S., Tapia, A., Chen, Z. B., & Ibrahim, S. H. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108372 · Cited by 38
Sheldon, R. D., Laughlin, M. H., & Rector, R. S. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01275.2013 · Cited by 35
Bae, C., Hino, J., Hosoda, H., Son, C., Makino, H., Tokudome, T., Tomita, T., Hosoda, K., Miyazato, M., & Kangawa, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-20469-z · Cited by 34
Lee, K., Hsieh, Y., Chan, C., Sun, H.-J., Huang, Y., Hou, M., & Lin, H. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0240-y · Cited by 33
The microenvironment in the development of MASLD-MASH-HCC and associated therapeutic in MASH-HCC
Wu, Q., Yang, Y., Lin, S., Geller, D. A., & Yan, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1569915 · Cited by 32
Baranski, T., Kraja, A. T., Fink, J. L., Feitosa, M. F., Lenzini, P. A., Borecki, I. B., Liu, C., Cupples, L. A., North, K. E., & Province, M. A. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007222 · Cited by 34
VASP Increases Hepatic Fatty Acid Oxidation by Activating AMPK in Mice
Tateya, S., Rizzo, N. O., Handa, P., Cheng, A. M., Morgan‐Stevenson, V., Ogimoto, K., Kanter, J. E., Bornfeldt, K., Daum, G., Clowes, A. W., et al. (2013) · Diabetes · doi:10.2337/db12-0325 · Cited by 32
“Primary hepatocyte cell culture was performed as previously described (11).”
BackgroundMethodInfluentialSelf-citationOit3, a promising hallmark gene for targeting liver sinusoidal endothelial cells
Li, Z., Ruan, B., Yang, P., Liu, J., Song, P., Duan, J., & Wang, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01621-2 · Cited by 33
“LSECs hold a pivotal and indispensable role in maintaining the homeostasis of the liver endothelial niche, 6 orchestrating hepatocytes, 7 hepatic stellate cells (HSCs), 8 and Kupffer cells (KCs) 9 by enacting the intricate process of angiocrine signaling.”
Hajihashemi, S., & Geuns, J. M. C. (2013) · Free Radicals and Antioxidants · doi:10.1016/j.fra.2013.10.001 · Cited by 41
Bruckbauer, A., Banerjee, J., Fu, L., Li, F., Cao, Q., Cui, X., Wu, R., Shi, H., Xue, B., & Zemel, M. B. (2016) · International Journal of Hepatology · doi:10.1155/2016/9185987 · Cited by 29
“lipid metabolism, as well as inflammation, oxidative stress, and cell proliferation, the key factors for progression of simple NAFLD to NASH and liver fibrosis [2, 14, 28, 29].”
BackgroundInfluentialOe, Y., Ko, M., Fushima, T., Sato, E., Karumanchi, S. A., Satō, H., Sugawara, J., Ito, S., & Takahashi, N. (2018) · Scientific Reports · doi:10.1038/s41598-017-18260-7 · Cited by 28
The Emerging Role of Hepatocellular eNOS in Non-alcoholic Fatty Liver Disease Development
Cunningham, R. P., Sheldon, R. D., & Rector, R. S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00767 · Cited by 31
Immunomodulatory activity of vardenafil on induced lung inflammation in cystic fibrosis mice
Lubamba, B., Huaux, F., Lebacq, J., Marbaix, É., Dhooghe, B., Panin, N., Wallemacq, P. E., & Leal, T. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.03.003 · Cited by 26
“Induction of proinflammatory activation of Kupffer cells, a differentiated hepatic monocyte cell subpopulation, in wild-type mice is coincident with reduced liver endothelial NO synthase activity and NO content while, conversely, enhancement of signaling downstream of NO-cGMP pathway through PDE5 inhibition has a prot…”
BackgroundJung, E., Baek, E. B., Hong, E.-J., Kang, J. H., Park, S., Park, S., Hong, E., Cho, Y., Ko, J., Won, Y., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.90781 · Cited by 26
“Sinusoidal capillarization is also observed in liver biopsies of alcoholic patients with mild fibrosis and increases as fibrosis progress to cirrhosis (Urashima et al., 1993).”
BackgroundResultVenkatesan, K., Paulsamy, P., Alqahtani, S., Asiri, Y. I., Alqahtani, T., Alqahtani, A., Sivadasan, D., Ahmed, R., Elfadil, H., Asseri, K. A., et al. (2025) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2025.100023 · Cited by 31
Felli, É., Nulan, Y., Ortega‐Ribera, M., Fernández‐Iglesias, A., & Gracia‐Sancho, J. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.10.017 · Cited by 39
The efficacy of PDE5 inhibitors in diabetic patients
Święcicka, A. (2022) · Andrology · doi:10.1111/andr.13328 · Cited by 25
Yan, M., Li, H., Xu, S., Wu, J., Li, J., Xiao, C., Mo, C., & Ding, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411313 · Cited by 31
Asada, S., Kaji, K., Nishimura, N., Koizumi, A., Matsuda, T., Tanaka, M., Yorioka, N., Sato, S., Kitagawa, K., Namisaki, T., et al. (2024) · Cells · doi:10.3390/cells13060538 · Cited by 25
Dai, Q., Ain, Q., Seth, N., Rooney, M., & Zipprich, A. (2025) · Digestive and Liver Disease · doi:10.1016/j.dld.2025.01.189 · Cited by 31
Goto, H., & Takamura, T. (2025) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes25017 · Cited by 30
Liu, Y., Liu, T., Zhang, F., & Gao, Y. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.87975 · Cited by 23
“Excessive alcohol consumption can lead to acetylation of Hsp90 and its reduced interaction with eNOS, which are potential mechanisms of LSEC dysfunction and liver injury [62].”
Kuś, K., Walczak, M., Kuś, E., Zakrzewska, A., Gonciarz, A., Zabielski, P., Sitek, B., Wandzel, K., Kij, A., Chabowski, A., et al. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.063388 · Cited by 21
“In fact, the NO/cGMP–dependent signaling pathway exerts an anti-inflammatory and antifibrotic effect by limiting Kupffer cell and hepatic stellate cell activation (Tateya et al., 2011).”
BackgroundVasodilator-stimulated phosphoprotein protects against vascular inflammation and insulin resistance
Cheng, A. M., Rizzo, N. O., Wilson, C. L., Lee, W. J., Tateya, S., Clowes, A. W., Schwartz, M. W., & Kim, F. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00303.2014 · Cited by 23
“The protective effect of VASP on vascular inflammation mimics our recent findings that phosphorylation of VASP is required for the effect of NO-cGMP signaling to limit obesityassociated adipose tissue inflammation (7) and that VASP deficiency induces liver inflammation in association with hepatic steatosis and insulin…”
BackgroundSelf-citationDai, Q., Ain, Q., Seth, N., Zhao, H., Rooney, M., & Zipprich, A. (2025) · Aging Cell · doi:10.1111/acel.14502 · Cited by 22
Gheibi, S., Jeddi, S., Carlström, M., Kashfi, K., & Ghasemi, A. (2019) · Nitric Oxide · doi:10.1016/j.niox.2019.08.006 · Cited by 20
Antinozzi, C., Sgrò, P., & Luigi, L. D. (2020) · International Journal of Endocrinology · doi:10.1155/2020/7078108 · Cited by 20
“, AKT and IRS-1), and GLUT4 translocation [22, 25, 37, 38], as well as inducing the activation of sirtuin-1 (SIRT1), a key sensor of cellular energy status [39–42].”
BackgroundNigris, V. D., Prattichizzo, F., Iijima, H., & Ceriello, A. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s302621 · Cited by 20
“A key regulator of macrophage polarization is endothelial nitric oxide (eNO), which polarizes macrophages from the M1 to the M2 phenotype, suggesting an implication of endothelial cell–macrophage interaction in inflammation.(6,7) However, its specific role under hyperglycemic conditions has not been fully evaluated.”
BackgroundGuanylate Cyclase C: A Current Hot Target, from Physiology to Pathology
Uranga, J. A., Castro, M., & Abalo, R. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867325666171205150310 · Cited by 19
CD47 differentially regulates white and brown fat function
Norman‐Burgdolf, H., Li, D., Sullivan, P. G., & Wang, S. (2020) · Biology Open · doi:10.1242/bio.056747 · Cited by 19
Capel, F., Chabrier, G., Pitois, E., Rigaudière, J., Plénier, S. L., Durand, C., Jouve, C., Bandt, J. P. D., Cynober, L., Moinard, C., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13269 · Cited by 20
“At the tissue level, dysregulation of NO production by liver endothelial cells exacerbates hepatic insulin resistance and several associated metabolic disorders, including liver steatosis (Tateya et al., 2011).”
BackgroundiNOS Gene Ablation Prevents Liver Fibrosis in Leptin-Deficient ob/ob Mice
Becerril, S., Rodríguez, A., Catalán, V., Ramírez, B., Unamuno, X., Gómez‐Ambrosi, J., & Frühbeck, G. (2019) · Genes · doi:10.3390/genes10030184 · Cited by 20
“The excessive NO generation triggers key processes involved in NAFLD progression, including mitochondrial biogenesis and function [50], Kupffer cell polarization [51], and HSC fibrogenesis [52], demonstrating an important role of iNOS in liver inflammation and fibrogenic response [53].”
BackgroundŞumlu, E., Bostancı, A., Sadı, G., Alçığır, M. E., & Akar, F. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1727527 · Cited by 18
“The studies also point out the existence of an efficient interaction between insulin signalling and endothelial nitric oxide synthase (eNOS) (Montagnani et al. 2001, Tateya et al. 2011).”
Backgroundvan Son, K. C., Verschuren, L., Hanemaaijer, R., Reeves, H. L., Takkenberg, R. B., Drenth, J. P. H., Tushuizen, M. E., & Holleboom, A. G. (2023) · Cancers · doi:10.3390/cancers15041308 · Cited by 19
Angiocrine Signaling in Sinusoidal Health and Disease
Cooper, S. A., Kostallari, E., & Shah, V. H. (2023) · Seminars in Liver Disease · doi:10.1055/a-2128-5907 · Cited by 15
“148 A recent study suggests that chronic liver disease can be ameliorated by inducing capillarized LSEC apoptosis.”
BackgroundCrosstalk in extrahepatic and hepatic system in NAFLD / NASH
Duan, Y., Yang, Y. Z., Zhao, S., Bai, Y., Yao, W., Gao, X., & Yin, J. (2024) · Liver International · doi:10.1111/liv.15967 · Cited by 17
Pamir, N., McMillen, T. S., Edgel, K. A., Kim, F., & LeBoeuf, R. C. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00447.2011 · Cited by 17
“The M2 phenotype is thought to be anti-inflammatory in nature (69) and not associated with insulin resistance, although we did see a preponderance of Arg1 mRNA for WT HFHS diet-fed mice in our study.”
MethodResultSelf-citationPriming metabolism with the type 5 phosphodiesterase: the role of cGMP-hydrolyzing enzymes
Campolo, F., Pofi, R., Venneri, M. A., & Isidori, A. M. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.08.007 · Cited by 18
Mo, H., Yue, P., Li, Q., Tan, Y., Yan, X., Liu, X., Xu, Y., Luo, Y., Palihati, S., Yi, C., et al. (2025) · Angiogenesis · doi:10.1007/s10456-025-09969-5 · Cited by 20
“…diminished endothelial NO signaling exacerbates HFD-induced hepatic inflammation, highlighting the role of the endothelial NO/vasodilator-stimulated phospho-protein (VASP) pathway in mitigating obesity-associated inflammation, insulin resistance in hepatocytes, and Kupfer cell activation [69].”
Shi, J., Li, Q., Li, J., Zhou, J., Zhang, X., Wang, S., & Guo, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137016 · Cited by 16
Xu, G., Li, Y., Jiang, X., & Chen, H. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25518 · Cited by 12
“Primary wild type and CAV1 / hepatocyte cell culture was performed as previously described [Tateya et al., 2011].”
MethodKuś, E., Jasiński, K., Skórka, T., Czyżyńska-Cichoń, I., & Chłopicki, S. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.11.019 · Cited by 12
Migdał, M., Tralle, E., Nahia, K. A., Bugajski, L., Kedzierska, K. Z., Garbicz, F., Piwocka, K., Winata, C., & Pawlak, M. (2021) · BMC Genomics · doi:10.1186/s12864-021-08173-1 · Cited by 9
“Some evidence shows that LSEC dysfunction occurs before other liver injury early markers including Kupffer cell activation, nitric oxide content reduction or TNFα, IL-6 and ICAM-1 up-regulation [67, 70, 72].”
BackgroundYıldırım, O. G., Güney, C., Alçığır, M. E., & Akar, F. (2023) · Reproductive Biology · doi:10.1016/j.repbio.2023.100815 · Cited by 8
Tang, J., Ding, Y., Chen, W., Shi, J., Zhang, C., Zhao, X., Li, J., Han, Z., & Chen, X. (2025) · Inflammation · doi:10.1007/s10753-025-02277-6 · Cited by 11
“VASP is implicated in the regulation of obesity-related inflammation and insulin resistance, and VASP knockout mice exhibit exacerbated liver inflammation in response to a high-fat diet [20, 21].”
Hasegawa, K., Akieda‐Asai, S., Fujii, Y., Bae, C., Yasuda, M., & Date, Y. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0193 · Cited by 8
Heparin modulation on hepatic nitric oxide synthase in experimental steatohepatitis
Hassanin, A., Malek, H. A., & Saleh, D. M. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1963 · Cited by 7
“Furthermore, Tateya et al (28) revealed that a HF diet induces liver inflammation and IR.”
From peel to health: jaboticaba’s phenolics counteract oxidative stress and liver fat buildup
Viana, K. W. C., Borges, L. L. R., Nascimento, A. L. A. A., Rigolon, T. C. B., Neves, N. D. A., da Matta, S. L. P., Wischral, D., Martins, E., Campelo, P. H., & Stringheta, P. C. (2025) · Food, Nutrition and Health. · doi:10.1007/s44403-025-00015-2 · Cited by 7
“The progression of the disease is fueled by the inflammatory process, which activates the Kupffer cells [79], that are essential for the control of inflammation [31].”
Hematopoietic Cell–Expressed Endothelial Nitric Oxide Protects the Liver From Insulin Resistance
Dick, B. P., McMahan, R. S., Knowles, T. O., Becker, L., Gharib, S. A., Vaisar, T., Wietecha, T., O’Brien, K. D., Bornfeldt, K., Chait, A., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313648 · Cited by 11
Self-citationHepatic nNOS impaired hepatic insulin sensitivity through the activation of p38 MAPK
Zhao, T., Li, Q., Mao, Q., Mu, K., & Wang, C. (2021) · Journal of Endocrinology · doi:10.1530/joe-20-0322 · Cited by 6
Metadata
- Authors
- Tateya, S., Rizzo, N. O., Handa, P., Cheng, A. M., Morgan-Stevenson, V., Daum, G., Clowes, A. W., Morton, G. J., Schwartz, M. W., & Kim, F.
- Affiliations
- University of Washington (US)
- Department of Medicine, University of Washington, Seattle, Washington
- Corresponding author
- Kim, Francis
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-10-17
- Volume
- 60
- Issue
- 11
- Pages
- 2792-2801
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3198085
- OpenAlex
- W2152816919
- Cited by
- 138
- References
- 35
- Citations by year
- 2026: 4 · 2025: 15 · 2024: 14 · 2023: 14 · 2022: 7 · 2021: 9 · 2020: 16 · 2019: 9 · 2018: 6 · 2017: 6 · 2016: 7 · 2015: 11 · 2014: 7 · 2013: 10 · 2012: 3
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Manpei Suzuki Diabetes Foundation
- National Institutes of Health (5r01dk073878-05)
- National Heart, Lung, and Blood Institute (HL-52459, R01HL052459, R37HL052459)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-083042, DK052989, R01DK052989, R01-DK-073878, DK-073878, R01DK090320, R01DK083042)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- endothelial nitric oxide, Kupffer cell activation, hepatic insulin resistance, high-fat diet, cGMP signaling, VASP, nitric oxide synthase, phosphodiesterase-5 inhibition, liver inflammation, obesity
- MeSH terms
- Vasodilator-Stimulated Phosphoprotein, Animals, Cells, Cultured, Dietary Fats, Gene Expression Regulation, Cyclic GMP, Hepatitis, Insulin Resistance, Kupffer Cells, Liver, Male, Mice, Inbred C57BL, Microfilament Proteins, Nitric Oxide, Obesity, Phosphoproteins, Signal Transduction, Cell Adhesion Molecules, Cytokines, Mice, Knockout, Endothelial Cells, Mice, Nitric Oxide Synthase Type III, Phosphodiesterase 5 Inhibitors, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.